With respect to the preservation of fertility options and perhaps, too, to prevent breast cancer, osteoporosis, and post-menopausal venous thrombosis, it would be safest to treat women with prolactin-sparing antipsychotics. The gene discussed is PRL; the disease is breast cancer.